Drug–Drug Interactions with Direct Oral Anticoagulants

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1179-1926

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Drug–Drug Interactions with Direct Oral Anticoagulants ; day:11 ; month:3 ; year:2020 ; pages:1-14
Clinical pharmacokinetics ; (11.3.2020), 1-14

Creator: Foerster, Kathrin
Hermann, Simon
Mikus, Gerd
Haefeli, Walter E.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40262-020-00879-x

URN: urn:nbn:de:101:1-2020060318593478764960

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:59 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Other Objects (12)

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants

Pharmacokinetics and pharmacodynamics of drug‒drug interactions in hospitalized older adults treated with direct oral anticoagulants

Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review

Pilot study on the probability of drug-drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective

Proactive monitoring of drug–drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy

Direct Oral Anticoagulants after Ischemic Stroke: Which Patient? Which Drug? And How Early?

A Review of Daclatasvir Drug–Drug Interactions

Extracting drug-drug interactions from biomedical texts

Lurasidone drug-drug interaction studies: a comprehensive review

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants

Pharmacokinetics and pharmacodynamics of drug‒drug interactions in hospitalized older adults treated with direct oral anticoagulants

Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review

Pilot study on the probability of drug-drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective

Proactive monitoring of drug–drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy

Direct Oral Anticoagulants after Ischemic Stroke: Which Patient? Which Drug? And How Early?

A Review of Daclatasvir Drug–Drug Interactions

Extracting drug-drug interactions from biomedical texts

Lurasidone drug-drug interaction studies: a comprehensive review

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants

Pharmacokinetics and pharmacodynamics of drug‒drug interactions in hospitalized older adults treated with direct oral anticoagulants

Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review

Pilot study on the probability of drug-drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective

Proactive monitoring of drug–drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy

Direct Oral Anticoagulants after Ischemic Stroke: Which Patient? Which Drug? And How Early?

A Review of Daclatasvir Drug–Drug Interactions

Extracting drug-drug interactions from biomedical texts

Lurasidone drug-drug interaction studies: a comprehensive review

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Drug–Drug Interactions with Direct Oral Anticoagulants

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants

Pharmacokinetics and pharmacodynamics of drug‒drug interactions in hospitalized older adults treated with direct oral anticoagulants

Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review

Pilot study on the probability of drug-drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective

Proactive monitoring of drug–drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy

Direct Oral Anticoagulants after Ischemic Stroke: Which Patient? Which Drug? And How Early?

A Review of Daclatasvir Drug–Drug Interactions

Extracting drug-drug interactions from biomedical texts

Lurasidone drug-drug interaction studies: a comprehensive review

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants

Pharmacokinetics and pharmacodynamics of drug‒drug interactions in hospitalized older adults treated with direct oral anticoagulants

Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review

Pilot study on the probability of drug-drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective

Proactive monitoring of drug–drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy

Direct Oral Anticoagulants after Ischemic Stroke: Which Patient? Which Drug? And How Early?

A Review of Daclatasvir Drug–Drug Interactions

Extracting drug-drug interactions from biomedical texts

Lurasidone drug-drug interaction studies: a comprehensive review

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants

Pharmacokinetics and pharmacodynamics of drug‒drug interactions in hospitalized older adults treated with direct oral anticoagulants

Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review

Pilot study on the probability of drug-drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective

Proactive monitoring of drug–drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy

Direct Oral Anticoagulants after Ischemic Stroke: Which Patient? Which Drug? And How Early?

A Review of Daclatasvir Drug–Drug Interactions

Extracting drug-drug interactions from biomedical texts

Lurasidone drug-drug interaction studies: a comprehensive review

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Related objects

Reset password